NDC 59368-003 - up and up dye free infants concentrated ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-003
- Package NDCs from labels
- 59368-003-01, 59368-003-02
- Manufacturer
- Sixarp, LLC
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| up and up dye free infants concentrated ibuprofen - Sixarp, LLC | Sixarp, LLC | 2024-03-15 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBUPROFEN | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f40f5-625d-3f2e-e053-2a95a90a438b | 2025-11-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f42a7-c2d8-4a51-e053-2a95a90a1677 | 2025-11-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f308f-0ca5-12fa-e053-2995a90a47fc | 2025-11-18 | Warnings | WK2XYI10QM |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | XF417D3PSL |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | WK2XYI10QM |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | WK2XYI10QM |
| good sense ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | c447fc6b-e9ef-447a-9609-5f893e18dfa7 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Family Dollar Services Inc | 89ed9311-2185-4660-b219-9ea67b1a71ec | 2025-11-15 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Topco Associates, LLC | bcf7d4c1-1f99-48df-8f74-9abeefa8d41d | 2025-11-15 | Warnings | WK2XYI10QM |
| Antifungal cream | ANTIFUNGAL CREAM | Guangzhou Guoyoumi Biotechnology Co Ltd | 43a5b3c8-3b99-b113-e063-6394a90a9aff | 2025-11-15 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | L.N.K. International, Inc. | d1f20e10-0128-f2e5-1a03-6da5d7288a4e | 2025-11-15 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | ARMY AND AIR FORCE EXCHANGE SERVICE | bf7d0929-a7d5-4164-9c24-566eddcd6489 | 2025-11-15 | Warnings | WK2XYI10QM |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | P & L Development, LLC | ce215099-91b0-43fd-8ac9-17fe6508842c | 2025-11-11 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.